dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1208694007

Production

Extended Map with ID “5f652512-1c36-5d19-93b6-6d381c2d82dc” doesn’t exist. Perhaps it was deleted?

Component

1208694007

The component that hold information about this concept.

Fully Specified Name (FSN)

Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)

Shortest Term

Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet

Definition Status

900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Summary

Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)

SCTID: 1208694007, Defined, Active

1208694007|Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)|

en Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
en Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)

Expression

1208694007 |Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)|
 === 421026006 |Conventional release oral tablet (dose form)| + 
732936001 |Tablet (unit of presentation)| + 
1208689007 |Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)| : 
        { 732943007 |Has basis of strength substance (attribute)| = 395828009 |Pioglitazone (substance)|,
762949000 |Has precise active ingredient (attribute)| = 116097005 |Pioglitazone hydrochloride (substance)|,
732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        { 732943007 |Has basis of strength substance (attribute)| = 702799001 |Alogliptin (substance)|,
762949000 |Has precise active ingredient (attribute)| = 702800002 |Alogliptin benzoate (substance)|,
732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        

Diagram

Active

Component help	Language Code help	Type	Term help	Case Significance help	Acceptability	Active
4970527014 - Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet (en) View
4970527014	en	Synonym (core metadata concept)	Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True
4970528016 - Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) (en) View
4970528016	en	Fully specified name (core metadata concept)	Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True

Type help	Destination help	Relationship group help	Characteristic type help	Active
Relationship (15099718025) - 1208694007 -> 1208689007 (116680003) View
116680003 \|Is a (attribute)\|	1208689007 \|Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099719022) - 1208694007 -> 421026006 (411116001) View
411116001 \|Has dose form (attribute)\|	421026006 \|Conventional release oral tablet (dose form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099720027) - 1208694007 -> 732936001 (763032000) View
763032000 \|Has unit of presentation (attribute)\|	732936001 \|Tablet (unit of presentation)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099722024) - 1208694007 -> 116097005 (762949000) View
762949000 \|Has precise active ingredient (attribute)\|	116097005 \|Pioglitazone hydrochloride (substance)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099723025) - 1208694007 -> 395828009 (732943007) View
732943007 \|Has basis of strength substance (attribute)\|	395828009 \|Pioglitazone (substance)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099725021) - 1208694007 -> 258684004 (732945000) View
732945000 \|Has presentation strength numerator unit (attribute)\|	258684004 \|Milligram (qualifier value)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099727029) - 1208694007 -> 732936001 (732947008) View
732947008 \|Has presentation strength denominator unit (attribute)\|	732936001 \|Tablet (unit of presentation)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099728023) - 1208694007 -> 702800002 (762949000) View
762949000 \|Has precise active ingredient (attribute)\|	702800002 \|Alogliptin benzoate (substance)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099729026) - 1208694007 -> 702799001 (732943007) View
732943007 \|Has basis of strength substance (attribute)\|	702799001 \|Alogliptin (substance)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099731024) - 1208694007 -> 258684004 (732945000) View
732945000 \|Has presentation strength numerator unit (attribute)\|	258684004 \|Milligram (qualifier value)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15099733022) - 1208694007 -> 732936001 (732947008) View
732947008 \|Has presentation strength denominator unit (attribute)\|	732936001 \|Tablet (unit of presentation)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active
1208689007 View
1208689007	Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Alogliptin and pioglitazone only product in oral dose form	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
421026006 View
421026006	Conventional release oral tablet (dose form)	Oral tablet	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
732936001 View
732936001	Tablet (unit of presentation)	Tablet	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active

Reference Set help	Map Target help	Map Rule help	Map Advice help	Correlation help	Map Category help

Terminology chevron_right Concepts chevron_right 1208694007

Descriptions

Relationships

Parent Concepts

Children Concepts

Extended Maps

Recent searches